Advertisement

Topics

NDI Guidance Could Drive Amarin's Gambit To Block Some Omega-3 Imports

19:58 EDT 9 May 2019 | SCRIP

Amarin's argument would swing on a finding by FDA that synthetics of omega-3s are not dietary ingredients. With such an...

      

Related Stories

 

Original Article: NDI Guidance Could Drive Amarin's Gambit To Block Some Omega-3 Imports

NEXT ARTICLE

More From BioPortfolio on "NDI Guidance Could Drive Amarin's Gambit To Block Some Omega-3 Imports"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...